Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Dairy - Aavin; key competitor of Hatsun losing market share - ICICI Sector

Posted On: 2020-09-13 22:04:23

Takeaways from Aavin's financials: (1) Its milk procurement has grown at CAGR of 6.1% vs 9.6% for Hatsun over FY11-19 indicating market share gains for Hatsun, (2) Hatsun has increased its realizations at rate higher than Aavin but still outperformed Aavin in volume growth over FY11-19, (3) Aavin has reported losses in 8 out of 12 years over FY08-19 whereas superior financials of Hatsun has allowed it to invest more in brand building and strengthen the moats, (4) Aavin has invested aggressively in animal feed business and volume CAGR of animal feed business is 45.3% over FY11-19. We believe this investment has helped Aavin to strengthen its relationship with the farmers and (5) Other dairies (Heritage and Parag) have limited presence in Tamil Nadu and are not material competitor to Hatsun or Aavin. Stock calls: retain BUY on Heritage, HOLD on Hatsun and Parag.

- Aavin, Tamil Nadu based Dairy co-operative: Aavin operates in Tamil Nadu as its major Dairy co-operative and has generated revenues of Rs60bn and procured milk 3.3mn liter per day in FY19. The products are largely sold under the brand Aavin and its sub brands. Aavin has introduced milk, curd (multiple variants), ghee, butter milk, paneer, ice cream (multiple variants) and sweets (mithai).

- Hatsun's milk procurement growing faster than Aavin: Aavin's milk procurement has increased at CAGR of 6.1% over FY11-19 whereas Hatsun's milk procurement increased at CAGR of 9.6% over same time. Considering milk production in Tamil Nadu has increased at CAGR of 2.6% over FY11-19, we note Hatsun has gained market share.

- Hatsun's revenues growing faster than Aavin: Hatsun reported revenue CAGR of 16.8% over FY08-19 compared to Aavin's revenue CAGR of 11.7%. Hatsun has not only outperformed in milk procurement, it has also reported higher realization CAGR compared to Aavin. We believe Hatsun was able to improve realizations at CAGR of 6.8% over FY11-19 due to (1) improving brand strength and (2) launch of premium products like Ibaco ice cream.

- Negligible profits/losses limit Aavin's ability to compete: Aavin has reported cumulative profit of just Rs176mn over FY08-19 whereas Hatsun reported cumulative profit of Rs6,419mn over FY08-19. We also note Aavin has reported losses in eight out of twelve years over FY08-19. Superior financials have helped Hatsun to better invest in brand building and also strengthen moats in the business.

- Other dairies in Tamil Nadu: Heritage has smaller presence in Tamil Nadu. We believe Tamil Nadu accounts for 7-9% of Heritage's revenues. Parag sells some value added products in Tamil Nadu but the revenue share of Tamil Nadu is less than 5%.

- Stock call: We maintain Heritage as our top pick in the dairy sector with a BUY rating. While we remain structurally positive on Hatsun, we need more comfort on valuations to turn bullish. Hence, we give a HOLD rating for Hatsun. Parag is likely to be impacted in the near term due to: (1) higher share of value-added products, and (2) higher B2B / HoReCa sales. Hence, we maintain our HOLD rating on Parag too.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Mazagon Dock IPO fully subscribed on Day 1 - Angel Broking

Pharma - Sector Thematic - Cardiac: the heartbeat of domestic market - HDFC Securities Institutional Research Desk

Walmart-Tata Retail Deal - Mr. Himanshu Nayyar, YES SECURITIES

HDFC Securities Institutional Research Desk: Chemical Conference Report

Lupin - Launch of Fosaprepitant - Angel Broking

Infosys - Key beneficiary of increased IT spending - Angel Broking

Gateway Distriparks - Holding structure simplified; prepared for next phase of growth - ICICI Securities

Visaka Industries - Demand and pricing tailwinds sustain; maintain a compelling BUY - ICICI Securities

GSK Pharmaceuticals - Analyst call highlights - Sep 28, 2020 - ICICI Securities

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019